Intrathecal chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: An experimental study

Cancer Research

Volumn 56, Issue 17, 1996, Pages 3986-3992

  Kitamura, Isao ^a   Kochi, Masato ^a   Matsumoto, Yoko ^b   Ueoka, Ryuichi ^b   Kuratsu, Jun Ichi ^a   Ushio, Yukitaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b SOJO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME; POLYSORBATE 20;

ANIMAL CELL; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER INHIBITION; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; DRUG EFFICACY; ENCAPSULATION; GLIOMA; HUMAN; HUMAN CELL; INTRATHECAL DRUG ADMINISTRATION; MENINGIOMA; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CELL DIVISION; DOGS; DRUG CARRIERS; GLIOMA; HUMANS; INJECTIONS, SPINAL; LIPOSOMES; MENINGEAL NEOPLASMS; MICE; RATS; RATS, WISTAR; TUMOR CELLS, CULTURED;

EID: 0029835663     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Yung, W A., Honen, B. C., and Shapiro, W R. Meningeal gliomatosis: a review of 12 cases Ann Neurol., 8: 605-608, 1980
2. Edwards, M. S., Levin, V. A., Seager, M. L., and Wilson, C. B Intrathecal chemotherapy for leptomeningeal dissemination of medulloblastoma. Child's Brain, 8: 444-451, 1981
3. Ushio, Y., Arita, N, Hayakawa, T., Morimoto, K., Ikeda, T., and Mogami, H. Chemotherapy of gliomas in children Nerv Syst. Child., 11: 349-354, 1986.
4. Fulton, D S., Levin, V A , Gutin, P. H , Edwards, M. S. B , Seager, M. L., Stewart, J., and Wilson, C. B. Intrathecal cytosine arabinoside for the treatment of meningeal metastases from malignant brain tumors and systemic tumors Cancer Chemother Pharmacol., 8: 285-291, 1982.
5. Gutin, P. H., Weiss, H. D , Wiernik, P. H., and Walker, M. D. Intrathecal N,N′,N′′-triethylenethiophosphoramide [thio TEPA (NCS6396)] in the treatment of malignant meningeal disease. Phase I-II study. Cancer (Phila.), 38: 1471-1475, 1976.
6. Gutin, P. H , Levi, J A., Wiernik, P. H , and Walker, M D. Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study. Cancer Treat. Rep., 61: 885-887, 1977.
7. Uemura, S. Experimental and clinical study of the treatment of malignant glioma J Kumamoto Med Soc., 59, 16-63, 1985.
8. Kochi, M., Kuratsu, J , Mihara, Y., Takaki, S., Inoue, N., Sueyoshi, N., Uemura, S., and Ushio, Y. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs Cancer Res , 50: 3119-3123, 1990.
9. Kochi, M., Kuratsu, J., Mihara, Y., Takaki, S., Seto, H., Uemura, S., and Ushio, Y. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethy])-1-nitrosourea hydrochloride Neurosurgery (Baltimore), 33: 817-823, 1993.
10. Kochi, M , Kuratsu, J., Mihara, Y , Takaki, S., Seto, H., Uemura, S., and Ushio, Y. Intrathecal perfusion of ACNU against subarachnoid dissemination of primary CNS tumors Nerv. Syst Child., 18: 273-279, 1993.
11. Green, S. B , Byar D. P., Walker M D., Pistenmaa, D A , Alexander, E., Jr., Batzdorf, U., Brooks, W. H , Hunt, W. E., Mealey, J, Jr., Odom, G L., Paoletti, P , Ransohoff, J., II, Robertson, J. T., Selker, R. G , Shapiro W., R., Smith, K R , Jr., Wilson, C. B., and Strike, T A. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat. Rep., 67: 121-132, 1983.
12. Walker, M D., Green, S. B., Byar, D. P., Alexander, E , Jr., Batzdorf, U , Brooks, W H , Hunt, W. E , MacCarty, C. S., Mahaley, M. S., Jr , Mealey, J., Jr., Owens, G , Ransohoff, J , II, Robertson, J T , Shapiro W., R., Smith, K. R., Jr., Wilson, C B , and Strike, T A Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N. Engl J. Med., 303: 1323-1329, 1980.
13. Matsumoto, Y., Imamura, C , Ito, T., Taniguchi, C , and Ueoka, R. Specific hybrid liposomes composed of phosphalidylcholine and polyoxyethylenealkyl ether with markedly enhanced inhibitory effects on the growth of tumor cells in vitro. Biol Pharm Bull., 18: 1456-1458, 1995.
14. Ueoka, R., Matsumoto, Y., Moss, R. A., Swarup, S., Sugu, A , Harada, K., Kikuchi, J , and Murakami, Y. Membrane matrix for the hydrolysis of ammo acid esters with marked enantioselectivity J Am. Chem. Soc., 110: 1588-1595, 1988.
15. Ueoka, R., and Matsumoto, Y. Developing new DDS using hybrid-tiposome. Biol. Ind., 10: 221-227, 1993.
16. Matsumoto, Y., Yamada, E., Hirano, J , Oshige, M., Ilio, M., Iwahara, M., and Ueoka, R. Specific inhibitory effect of hybrid-liposome on growth of human lymphoma-human lymphocyte B hybridoma cells in vitro. Biol. Pharm. Bull , 16: 213-215, 1993
17. Pontén, J., and Macintyre, E. H. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol Scand , 74: 465-486, 1968.
18. Westermark, B., Pontén, J., and Hugosson, R. Determinants for the establishment of permanent tissue culture lines from human gliomas. Acta Pathol. Microbioi Scand. Sect. A Pathol., 81: 791-805, 1973
19. Westermark, B. The deficient density-dependent growth control of human malignant glioma cells and virus-transformed glia-like cells in culture Int. J. Cancer, 12: 438-451, 1973
20. Benda, P., Lightbody, J , Sato, G , Levine, L., and Sweet, W. Differentiated rat glial cell strain in tissue culture Science (Washington DC), 161. 370-371, 1968.
21. Barker, M , Hoshino, T., Gurcay, O., Wilson, C B , Nielsen, S. L., Downie, R., and Eliason, J. Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res., 33, 976-986, 1973
22. Mosmann, T. Rapid colonmetric assay for cellular growth and survival: application to proliferation and cytotoxicily assays. J Immunol. Methods, 65: 55-63, 1983
23. Nikkhah, G., Tonn, J. C. Hoffmann, O , Kraemer, H P., Darling, J. L, Schachenmuyr, W., and Schönmayr, R The MTT assay for chemosensitivity testing of human tumors of the central nervous system. I. Evaluation of test-specific variables. J. Neuro-oncol , 13 1-11, 1992.
24. Ushio, Y , Chernik, N. L., Posner, J. B., and Shapiro, W. R. Meningeal carcinomatosis: development of an experimental model J Neuropathol. Exp. Neurol., 36: 228-244, 1977
25. Levin, V. A., and Levin, E. M. Dissolution and stability of carmustine in the absence of ethanol. Sel. Cancer Ther., 5: 33-35, 1989.
26. Kim, S. Liposomes as earners of cancer chemotherapy. Drugs. 46: 618-638, 1993
27. Ritter, C., and Rutman, R J. Relative enhancement by various liposomes of BCNU effectiveness against L-1210 leukemia in vivo. Res. Commun Chem. Pathol. Pharmacol., 30: 123-131, 1980
28. Inaba, M., Yoshida, N., and Tsukagoshi, S Preferential action of liposome-entrapped 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on lung metastasis of Lewis lung carcinoma as compared with the free drug. Gann, 72: 341-345, 1981.
29. Takenaga, M., Igarashi, R., Tsuji, H , and Mizushima, Y Enhanced antitumor activity and reduced toxicity of 1,3-Bis(2-chloroethyl)-1-nitrosourea administered in lipid microspheres to tumor-bearing mice. Jpn. J. Cancer Res., 84, 1078-1085, 1993.
30. 3H]methotrexate in the central nervous system after intracerebroventricular injection in a primate. Cancer Res., 38 706-712, 1978.
31. Kim, S., Kim, D. J., Geyer, M. A., and Howell, S B Multivesicular liposomes containing 1-β-D-arabinofuranosylcytosine for slow-release intrathecal therapy Cancer Res., 47: 3935-3937, 1987.
32. Kim, S., Khatibi, S , Howell, S. B., McCully, C., Balis, F M., and Poplack, D G. Prolongation of drug exposure m cerebrospinal fluid by encapsulation into Depo-Foam Cancer Res., 53: 1596-1598, 1993
33. Kim, S , Chatelut, E., Kim, J. C , Howell, S B., Cates, C , Kormanic, P A., and Chamberlain, M. C. Extended CSF. Cytarabine exposure following intrathecal administration of DTC 101 J. Clin. Oncol., 11: 2186-2193, 1993.
34. Levin, V A , Byrd, D., Campbell, J., Giannini, D. D., Borcich, J. K., and Davis, R. L. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitrosourea and other nitrosoureas in beagles Cancer Res , 45: 3803-3809, 1985.
35. Nagatani, M , Anta, N , Ushio, Y., Hayakawa, T , Tzuu-Yuan, H., Yoshimine, T , Mori, S., and Mogami, H. Intrathecal ACNU against malignant leptomeningeal tumor: toxicity and therapeutic effect m experimental animals. Brain Nerve (Tokyo), 38: 1071-1075, 1986
36. Sasaoka, N. Chemosensitivity assays for malignant gliomas. Gan To Kagaku Ryoho, 17: 2247-2252, 1990.
37. Yung, W. K. A. In vitro Chemosensitivity testing and its clinical application in human gliomas. Neurosurg. Rev., 12: 197-203, 1989.
38. Nomura, K., Yamamoto, H., Shibui, S., Miki, Y., and Seki, M Application of flow cytometric analysis to brain tumor chemotherapy. 1. Changes of cell kinetics induced by anticancer drugs. Neurol Surg , 33: 341-350, 1981.